SUOX Antibody (6H0C9)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-15302
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 6H0C9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 100-200 of human SUOX (P51687). IWVTLGSEVFDVTEFVDLHPGGPSKLMLAAGGPLEPFWALYAVHNQSHVRELLAQYKIGELNPEDKVAPTVETSDPYADDPVRHPALKVNSQRPFNAEPPP
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SUOX Antibody (6H0C9)
Western Blot: SUOX Antibody (6H0C9) [NBP3-15302]
Western Blot: SUOX Antibody (6H0C9) [NBP3-15302] - Western blot analysis of extracts of Rat kidney, using SUOX antibody (NBP3-15302) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 30s.Applications for SUOX Antibody (6H0C9)
Application
Recommended Usage
Western Blot
1:500 - 1:1000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 0.05% BSA, 50% glycerol, pH7.3
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SUOX
Alternate Names
EC 1.8.3.1, sulfite oxidase, sulfite oxidase, mitochondrial
Gene Symbol
SUOX
Additional SUOX Products
Product Documents for SUOX Antibody (6H0C9)
Product Specific Notices for SUOX Antibody (6H0C9)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...